Daniel Pla
University of Barcelona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daniel Pla.
Anti-cancer Agents in Medicinal Chemistry | 2008
Daniel Pla; Fernando Albericio; Mercedes Álvarez
Lamellarins are a large family of marine alkaloids with potential anticancer activity that have been isolated from diverse marine organisms, mainly ascidians and sponges. All lamellarins feature a 3,4-diarylpyrrole system. Pentacyclic lamellarins, whose polyheterocyclic system has a pyrrole core, are the most active compounds. Some of these alkaloids are potently cytotoxic to various tumor cell lines. To date, Lam-D and Lam-H have been identified as lead compounds for the inhibition of topoisomerase I and HIV-1 integrase, respectively-nuclear enzymes which are over-expressed in deregulation disorders. Moreover, these compounds have been reported for their efficacy in treatment of multi-drug resistant (MDR) tumors cells without mediated drug efflux, as well as their immunomodulatory activity and selectivity towards melanoma cell lines. This article is an overview of recent literature on lamellarins, encompassing their isolation, recent synthetic strategies for their total synthesis, the preparation of their analogs, studies on their mechanisms of action, and their structure-activity relationships (SAR).
MedChemComm | 2011
Daniel Pla; Fernando Albericio; Mercedes Álvarez
This review covers recent literature on the lamellarins, a family of marine natural products, and related analogs, encompassing synthetic strategies for total synthesis, structure–activity relationships (SAR), and studies on mechanisms of biological action, namely in the context of anti-tumor activity. It reviews work published from January 2008 to December 2010.
Journal of Medicinal Chemistry | 2009
Miroslav Šíša; Daniel Pla; Marta Altuna; Andrés Francesch; Carmen Cuevas; Fernando Albericio; Mercedes Álvarez
The first total synthesis of the indole alkaloids (+/-)-aplicyanins A, B, and E, plus 17 analogues, all in racemic form, is reported. Modifications to the parent compound included changing the number of bromine substituents on the indole, the nature of the substituents on the indole nitrogen (H, Me, or OMe), and/or the oxidation level of the heterocyclic core tetrahydropyrimidine. Each compound was screened against three human tumor cell lines, and 14 of the newly synthesized compounds showed considerable cytotoxicity. The assay results were used to establish structure-activity relationships. These results suggest that the presence of the bromine at position 5 of the indole is critical to activity, as well as the acetyl group on the imine nitrogen does in some compounds.
Journal of Organic Chemistry | 2010
Adriana Lorente; Daniel Pla; Librada M. Cañedo; Fernando Albericio; Mercedes Álvarez
Barmumycin was isolated from an extract of the marine actinomycete Streptomyces sp. BOSC-022A and found to be cytotoxic against various human tumor cell lines. On the basis of preliminary one- and two-dimensional (1)H and (13)C NMR spectra, the natural compound was initially assigned the structure of macrolactone-type compound 1, which was later prepared by two different routes. However, major spectroscopic differences between isolated barmumycin and 1 led to revision of the proposed structure as E-16. On the basis of the synthesis of this new compound, and subsequent spectroscopic comparison of it to an authentic sample of barmumycin, the structure of the natural compound was indeed confirmed as that of E-16.
Bioconjugate Chemistry | 2009
Daniel Pla; Marc Martí; Josep Farrera-Sinfreu; Daniel Pulido; Andrés Francesch; Pilar Calvo; Carmen Cuevas; Miriam Royo; Rosa Aligué; Fernando Albericio; Mercedes Álvarez
The design and synthesis of Lamellarin D conjugates with a nuclear localization signal peptide and a poly(ethylene glycol)-based dendrimer are described. Conjugates 1-4 were obtained in 8-84% overall yields from the corresponding protected Lamellarin D. Conjugates 1 and 4 are 1.4- to 3.3-fold more cytotoxic than the parent compound against three human tumor cell lines (MDA-MB-231 breast, A-549 lung, and HT-29 colon). Besides, conjugates 3 and 4 showed a decrease in activity potency in BJ skin fibroblasts, a normal cell culture. Cellular internalization was analyzed, and a nuclear distribution pattern was observed for 4, which contains a nuclear localization signaling sequence.
Bioconjugate Chemistry | 2009
Daniel Pla; Andrés Francesch; Pilar Calvo; Carmen Cuevas; Rosa Aligué; Fernando Albericio; Mercedes Álvarez
Herein is reported the design and synthesis of poly(ethylene glycol) derivatives of Lamellarin D with the aim of modulating their physicochemical properties and improving the biological activity. Mono-, di-, and tri-PEG conjugates with improved solubility were obtained in 18-57% overall yields from the corresponding partially protected phenolic derivatives of Lamellarin D. Conjugates 1-9 were tested in a panel of three human tumor cell lines (MDA-MB-231 breast, A-549 lung, and HT-29 colon) to evaluate their cytotoxicity. Several compounds exhibited enhanced cellular internalization, and more than 85% of the derivatives showed a lower GI(50) than Lam-D. Furthermore, cell cycle arrest at G2 phase and apoptotic cell-death pathways were determined for Lamellarin D and these derivatives.
Archive | 2010
Fernando Albericio; Mercedes Álvarez; Carmen Cuevas; Andrés Francesch; Daniel Pla; Judit Tulla-Puche
The role of natural products in drug discovery has suffered ups and downs during the past few years. Recently, and as the number of classical drugs has not been increasing greatly, it seems that pharmaceutical companies are looking again towards nature as an inspiration for new drugs. Especially interesting has been the fact that during the past few years the first drugs based on natural marine products have been introduced in the markel. showing the enormous potential of the sea as a source of drugs. One of the main problems associated with the use of natural products as therapeutics is their poor pharmacokinetic properties. A strategy for improving these properties is through their chemical modification, which is exemplified herein by work on such structural edition of two natural products (thiocoraline and lamellarin) currently being carried out at our laboratories.
Journal of Medicinal Chemistry | 2006
Daniel Pla; Antonio Marchal; Christian A. Olsen; Andrés Francesch; Carmen Cuevas; Fernando Albericio; Mercedes Álvarez
Journal of Organic Chemistry | 2005
Daniel Pla; Antonio Marchal; Christian A. Olsen; Fernando Albericio; Mercedes Álvarez
European Journal of Organic Chemistry | 2007
Daniel Pla; Fernando Albericio; Mercedes Álvarez